Skip to content
Screener

ClearPoint Neuro CLPT Other Non-Current Assets

Other Non-Current Assets at other companies

IAR
Integra LifeSciencesIART
$69.7M+16.6%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.08B+4.6%
Medtronic logo
MedtronicMDT
$4.15B+15.7%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.23M-8.1%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$98K+12.6%
LivaNova logo
LivaNovaLIVN
$18.31M+27.8%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$444.45M+48.3%
Enterprise value$471.52M+60.7%
P/S10.9×+2.0×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 5:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-221890
Line itemMarch 31, 2026 / (Unaudited)December 31, 2025
Operating lease, right-of-use assets13,0888,430
Goodwill7,4727,472
Intangible assets, net13,41913,922
Other assets1,6461,702
Total assets$93,416$97,747
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$2,330$1,256

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is ClearPoint Neuro's other non-current assets?
ClearPoint Neuro (CLPT) reported other non-current assets of $1.65M in Q1 2026.
How has ClearPoint Neuro's other non-current assets changed year-over-year?
ClearPoint Neuro's other non-current assets increased by 1012.2% year-over-year, from $148K to $1.65M.
What is the long-term trend for ClearPoint Neuro's other non-current assets?
Over 5 years (2020 to 2025), ClearPoint Neuro's other non-current assets has grown at a 95.9% compound annual growth rate (CAGR), from $59K to $1.7M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about ClearPoint Neuro's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude